26 peer-reviewed studies · Evidence score: 8/10
Zádor E • Cells (2025)
The similarities with agents mimicking calorie restriction and anti-aging effects are also elucidated and discussed.
Krishnan N • Advances in experimental medicine and biology (2026)
The Author(s), under exclusive license to Springer Nature Switzerland AG.
Todorova V et al. • Nutrients (2024)
However, the therapeutic potential of phytoecdysteroid-rich extracts extends beyond sports nutrition, with promising applications in treating chronic fatigue, cardiovascular diseases, and neurodegenerative disorders.
Gáliková M et al. • Seminars in cell & developmental biology (2023)
In this review, we focus on a selection of the most important catabolic regulators from the group of peptide hormones (Adipokinetic hormone, Corazonin), catecholamines (octopamine), steroid hormone...
Arif Y et al. • International journal of molecular sciences (2022)
In humans, PEs display biological, pharmacological, and medicinal properties, such as anti-diabetic, antioxidant, anti-microbial, hepatoprotective, hypoglycemic, anti-cancer, anti-inflammatory, antidepressant, and tissue differentiation activity.
Ekoka E et al. • Parasites & vectors (2021)
Finally, we discuss the potential of using chemicals targeting 20E signaling to control malaria vectors.
Zhao XF • Cell communication and signaling : CCS (2020)
This systematic-review examined the effects of Beta-Ecdysterone.
Lapenna S et al. • Critical reviews in food science and nutrition (2015)
We call for additional research to validate the safety and health-promoting properties of PEs and other herbal compounds, for the benefit of all consumers.
Bouyahya A et al. • Journal of ethnopharmacology (2020)
A. iva extracts especially from the leaves showed significant antidiabetic, antioxidant, anti-hypercholesterolemia, and analgesic effects.
Zhang ND et al. • Journal of ethnopharmacology (2016)
Clinical practice and animal experiments indicate that TCM formulas provide a definite therapeutic effect on osteoporosis.
Simnadis TG et al. • Plant foods for human nutrition (Dordrecht, Netherlands) (2015)
The role of quinoa as an antioxidant is still unclear and requires further elucidation in animal models.
Negi JS et al. • Anti-cancer agents in medicinal chemistry (2014)
Consequently, this review will be helpful to the researcher and scientist for further research.
Kleino A et al. • Developmental and comparative immunology (2014)
During the last two decades, significant progress has been made in identifying the components and deciphering the molecular mechanisms underlying this pathway, including the means of bacterial sens...
Volodin VV et al. • Voprosy pitaniia (2013)
The prospects of using the 20-hydroxyecdysone in the composition of food supplements and specialized products for athletes are discussed.
Cahlíková L et al. • Natural product communications (2011)
Because of these properties, ecdysterone has the potential to be developed as a medicinal agent.
Latil M et al. • Drug discovery today (2021)
The clinical picture of COVID-19, and the fact that Angiotensin converting enzyme 2 (ACE2) is a receptor of SARS-CoV-2, suggests that SARS-CoV-2 infection induces an imbalance in the renin-angioten...
Fielding RA et al. • Journal of cachexia, sarcopenia and muscle (2025)
After 6 to 9 months of treatment, BIO101 350 mg bid showed strong trends consistent with a clinically relevant effect on the 400MWT GS, close to the minimal clinically important difference (MCID) in sarcopenia (0.1 m/s).
Dissemond J et al. • Journal of the International Society of Sports Nutrition (2025)
This study demonstrated that the prescribed resistance training protocol resulted in significant anabolic and performance-enhancing effects that did not differ between groups.
Prasertsri P et al. • International journal of molecular sciences (2025)
These findings suggest that combining HIIT with ARE supplementation produces synergistic improvements in oxidative and inflammatory status, whereas HIIT alone primarily enhances metabolic regulation in overweight and obese individuals.
Dioh W et al. • Journal of cachexia, sarcopenia and muscle (2023)
BIO101 shows a good safety and pharmacokinetic profile that led to the selection of doses for the subsequent interventional clinical trials of Phase 2 in age-related sarcopenia (SARA-INT) and Phase 3 in Covid-19 (COVA).